Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9606 USD | -4.90% | -4.89% | -86.66% |
05-16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
05-16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AEON BIOPHARMA, INC. | Bio Therapeutic Drugs | -4.90% | -4.89% | -86.66% | -87.11% | - | 39.51M |
Technical Rankings Surperformance
- Stock Market
- Equities
- AEON Stock
- Charts AEON Biopharma, Inc.
- Comparison Chart